ENSEMBLE THERAPEUTICS CORP has a total of 17 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are UNIBIOS SPA, GHOSH ARUN K and FUJIAN HAIXI PHARMACEUTICALS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Canada | 2 | |
#5 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Borzilleri Robert M | 7 |
#2 | Zhang Yong | 7 |
#3 | Seigal Benjamin A | 6 |
#4 | Miller Michael M | 6 |
#5 | Terrett Nicholas K | 5 |
#6 | Hale Stephen P | 5 |
#7 | Briggs Timothy F | 5 |
#8 | Snedeker Cheri | 4 |
#9 | Cipriani Tyler J | 4 |
#10 | Shortsleeves Kelley C | 4 |
Publication | Filing date | Title |
---|---|---|
WO2018102006A1 | Compounds for the inhibition of indoleamine-2,3-dioxygenase activity and use thereof | |
WO2018053302A1 | Macrocyclic compounds for the inhibition of indoleamine-2,3-dioxygenase activity and use thereof | |
WO2016109808A1 | Methods and compositions for nucleic acid-templated synthesis of large libraries of complex small molecules | |
US2015005319A1 | Macrocyclic compounds for modulating IL-17 | |
EP2776409A1 | Macrocyclic compounds for inhibition of inhibitors of apoptosis | |
EP2350031A2 | Macrocyclic compounds for inhibition of tumor necrosis factor alpha |